Imagine being able to switch individual brain cells on and off as easily as turning on a light. It sounds like something from a science fiction movie, but researchers have developed a technique that makes exactly that possible.
The discovery has transformed how scientists investigate the brain, allowing them to study the cells responsible for everything from memories and emotions to movement and behavior.
Now, the three scientists behind the breakthrough have received one of the world's most prestigious awards.
On October 5, 2026, the Nobel Assembly at Karolinska Institutet announced that Karl Deisseroth, Peter Hegemann and Georg Nagel had won the Nobel Prize in Physiology or Medicine for developing a groundbreaking technique called optogenetics.
Also read: Scientists test AI-powered headset that could change how women manage menopause symptoms
According to STAT News, the discovery allows researchers to control carefully selected nerve cells using light, offering an entirely new way to understand how the brain works.
And the technology is already moving beyond laboratory experiments, with researchers investigating whether it could help restore limited vision to people living with certain forms of blindness.
The breakthrough began with something found in green algae
The discovery has an unusual origin. Instead of beginning with the human brain, it started with scientists trying to understand how tiny green algae move toward sunlight.
In the 1990s, German researcher Peter Hegemann became interested in a microscopic, single-celled organism called Chlamydomonas. Although it has no brain, the organism can detect light and swim toward it, helping it find the energy it needs to survive.
Also read: Scientists discover surprising link between breakfast and how well we handle stress
Hegemann and fellow scientist Georg Nagel eventually discovered a special protein responsible for this remarkable ability.
The protein, called channelrhodopsin, acts like a tiny gate in the cell's outer surface. When blue light reaches it, the gate opens and allows electrically charged particles to move through.
That movement creates an electrical signal inside the cell, allowing it to respond to light almost immediately.
What made the discovery particularly exciting was that the protein could also work in other types of cells.
Also read: The 10,000-step rule could be changing as new research points to a lower target
According to the official Nobel Prize explanation published by Karolinska Institutet, the researchers found that cells could become sensitive to light when they were given the biological instructions needed to produce the protein.
That finding opened the door to something far more ambitious: using light to control the electrical signals inside the brain.
Scientists discovered how to control brain cells using light
American neuroscientist Karl Deisseroth, a professor at Stanford University, helped turn the discovery into a powerful research tool.
In 2005, his research team demonstrated that nerve cells could be made sensitive to blue light by introducing the gene responsible for producing channelrhodopsin.
Also read: This common salad topping is linked to 76 illnesses, and washing it may not be enough
When researchers directed light at these modified cells, they could trigger electrical activity almost instantly. Later experiments showed that the same principle worked in the brains of living animals.
The technology became known as optogenetics, a combination of genetics and light.
The basic idea is relatively simple. Scientists first make certain nerve cells sensitive to light by giving them instructions to produce a light-reactive protein. They can then use carefully controlled flashes of light to activate those cells.
Other versions of the technology can reduce or stop the activity of particular cells.
Also read: A pre-meal protein habit may cut your blood sugar spike by about 28%
Unlike traditional methods that affect large areas of the brain, optogenetics allows researchers to target specific groups of neurons with extraordinary precision.
In laboratory experiments, light is often delivered through a very thin optical fiber positioned near the cells researchers want to investigate.
Speaking to STAT following the Nobel announcement, Deisseroth explained what makes the approach different.
"We’re not using light to collect information, we’re using light to cause things to happen," he said.
This gives researchers a way to investigate not just which brain cells are active during certain experiences, but whether activating those cells actually changes what an animal does.
The discovery is changing how we understand the brain
The human brain contains approximately 86 billion neurons, which communicate through an enormous network of electrical and chemical signals.
For decades, scientists have struggled to understand exactly which cells control particular functions. Brain scans can reveal which areas become active when someone moves, remembers something or experiences an emotion, but they cannot always establish which cells are responsible.
Optogenetics offers a different approach.
By activating or suppressing carefully selected neurons, researchers can observe what happens to an animal's behavior and learn more about the brain circuits involved.
Scientists have already used the technique to investigate memory, sleep, pain, movement and emotional responses in laboratory animals.
For example, researchers can activate specific neural circuits in mice and observe changes in their behavior. These experiments can provide clues about how the brain processes experiences and why certain functions change during neurological or psychiatric disorders.
Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine, highlighted the significance of the technology.
"Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of," he said.
However, understanding how individual brain circuits work is different from being able to treat disease. Most applications involving brain cells remain experimental, and the technology is not an established treatment for conditions such as Parkinson's disease, epilepsy or depression.
A new study suggests the technology could help people with blindness
One of the most promising medical applications is emerging outside the brain itself.
Researchers are investigating whether optogenetics could restore some visual abilities in people with retinitis pigmentosa, a group of inherited eye diseases that gradually damage the cells responsible for detecting light.
As the disease progresses, patients can lose their ability to see objects, recognize shapes and navigate their surroundings. In severe cases, the condition causes blindness.
The idea behind the experimental treatment is to make surviving cells in the retina sensitive to light, allowing them to send signals to the brain even after the eye's original light-detecting cells have been damaged.
Some approaches use modified viruses to deliver the genetic instructions for producing light-sensitive proteins. Patients then wear specially designed goggles that convert visual information into light signals capable of activating the modified retinal cells.
An early breakthrough was described in Scientific American in 2021, when researchers reported that a man who had experienced severe vision loss for decades regained the ability to detect and locate certain objects using the experimental treatment.
But a more recent study suggests that the technology's potential extends beyond a single patient.
Six patients showed meaningful improvements in light sensitivity
On October 7, 2026, just two days after the Nobel Prize announcement, researchers published new findings in the New England Journal of Medicine.
The study involved 10 people with advanced retinitis pigmentosa who received an experimental treatment combining gene therapy with specialized light-stimulating goggles.
The researchers found that light sensitivity increased in seven participants, with six showing improvements considered clinically meaningful under the study's criteria.
Some participants also performed better on practical tests involving detecting objects, finding doorways and navigating their surroundings while wearing the goggles.
According to the Institute of Molecular and Clinical Ophthalmology Basel, the findings suggest that the technology may help recover certain aspects of visual function even when retinal damage is already severe.
However, the treatment did not restore normal sight. The study was small, its main objective was to investigate safety, and researchers recorded eye-related adverse events, including one severe but temporary complication.
Larger studies will therefore be needed to establish how effective the treatment is, which patients could benefit and whether the improvements can be maintained over time.
Could the same technology eventually treat brain disorders?
The possibilities extend beyond inherited blindness.
Scientists are exploring whether optogenetics could one day help treat neurological conditions involving abnormal activity in specific brain circuits.
Parkinson's disease, for example, affects the systems responsible for controlling movement. Researchers hope that a better understanding of these circuits could lead to more precise treatments.
Epilepsy is another area of interest because seizures involve unusual electrical activity in the brain. In theory, selectively controlling certain nerve cells could provide a way to investigate or interrupt that activity.
But applying optogenetics inside the human brain presents major challenges.
Researchers would need to deliver genetic material safely to the correct cells and provide light to the targeted area without damaging surrounding tissue. They would also need to demonstrate that controlling those cells improves symptoms without causing unacceptable side effects.
These challenges help explain why clinical applications have initially focused on the retina, where light can reach the modified cells more easily.
For now, optogenetics remains primarily a powerful research technique rather than a routine medical treatment.
A discovery that could shape the future of medicine
The 2026 Nobel Prize recognizes a breakthrough that has fundamentally changed how scientists investigate the nervous system.
What began as an effort to understand how microscopic algae respond to sunlight has become a method for controlling some of the most complicated cells in the human body.
The technology is already helping researchers explore how memories form, how emotions influence behavior and how diseases disrupt normal brain activity.
And with clinical trials beginning to show measurable improvements in certain forms of severe vision loss, its potential medical applications are becoming increasingly tangible.
There is still a long distance between switching cells on and off in laboratory experiments and developing safe, effective treatments for people with neurological diseases.
But the research recognized by this year's Nobel Prize has given scientists something they previously lacked: a way to control specific nerve cells with remarkable speed and precision.
That achievement may prove to be as important for future medical discoveries as it already has been for our understanding of the brain.
This article is made and published by Aksel Kryhlmand, who may have used AI in the preparation.